Immune System News and Research

RSS

Scientists discover new class of polymers that are resistant to bacterial attachment

Using state-of-the-art technology scientists at The University of Nottingham have discovered a new class of polymers that are resistant to bacterial attachment. These new materials could lead to a significant reduction in hospital infections and medical device failures.

13 Aug 2012

New 3-D view of the body's response to infection

A new 3-D view of the body's response to infection - and the ability to identify proteins involved in the response - could point to novel biomarkers and therapeutic agents for infectious diseases.

13 Aug 2012

Promising stem cell therapy may prevent osteoarthritis after joint injury

Duke researchers may have found a promising stem cell therapy for preventing osteoarthritis after a joint injury.

10 Aug 2012

Allergies appear to lower brain tumor risk

Testing positive for immunoglobulin E, a biomarker of allergy, reduces a person’s risk for developing glioma, show study findings.

10 Aug 2012

Link between chronic exposure to staph bacteria and risk of lupus

Chronic exposure to even small amounts of staph bacteria could be a risk factor for the chronic inflammatory disease lupus, Mayo Clinic research shows. Staph, short for Staphylococcus aureus, is a germ commonly found on the skin or in the nose, sometimes causing infections.

9 Aug 2012

Abacus, SurePoint Medical partner to offer diabetes-care plan for employers

SurePoint Medical, provider of direct-to-consumer healthcare supplies and disease-management services, today announced a strategic partnership with Abacus Employer Health Solutions (Abacus) to offer its SurePoint Wellness diabetes-care plan to companies that use Abacus's Good Health Gateway employee health management program.

9 Aug 2012

Data from IMUC’s ICT-107 Phase I trial on glioblastoma multiforme accepted for publication

ImmunoCellular Therapeutics announced today that clinical data from its Phase I trial of ICT-107 was accepted for publication, and is currently in the online edition of the prestigious medical journal Cancer Immunology, Immunotherapy.

9 Aug 2012

New method gives precise picture of how immune system works

Chronic infections are a large and growing problem throughout the developed world, and intensive research is being conducted in ways to combat the recalcitrant bacteria. When bacteria aggregate into so-called biofilm, they become resistant to antibiotics. Until now scientists have only been able to speculate about what happens when bacteria overpower the immune system during a chronic infection.

9 Aug 2012

Theranostic imaging targets and tracks potent drug therapies to prostate cancer cells

Experimenting with human prostate cancer cells and mice, cancer imaging experts at Johns Hopkins say they have developed a method for finding and killing malignant cells while sparing healthy ones.

9 Aug 2012

Covalon’s IV Clear antimicrobial clear silicone dressing to be presented at FIME 2012

Covalon Technologies Ltd., an advanced medical technologies company, today announced that it is presenting its latest breakthrough antimicrobial products, including the recently United States FDA cleared IV Clear at the 2012 FIME International Medical Expo from August 8 to 10 in Miami Beach, Florida.

9 Aug 2012

Neutrophils help kick off insulin resistance in obesity

Experts have found that neutrophils play an important role in initiating the chronic inflammation that characterizes obesity-induced insulin resistance.

8 Aug 2012

Prostate cancer cells can be killed by theranostic imaging without harming healthy cells

Experimenting with human prostate cancer cells and mice, cancer imaging experts at Johns Hopkins say they have developed a method for finding and killing malignant cells while sparing healthy ones.

8 Aug 2012

Neutral-pressure IV connector eliminates catheter-related bloodstream infections in cancer patients

A neutral-pressure IV needleless connector was associated with complete elimination of catheter-related bloodstream infections (CRBSI) in a successful device trial at a large cancer center in the six-month period following implementation of the device.

8 Aug 2012

New clinical trial to study how worm eggs may relieve symptoms of ulcerative colitis

A new clinical trial designed to study how worm eggs may relieve symptoms of ulcerative colitis (UC) will begin enrolling patients at NYU School of Medicine's Clinical and Translational Science Institute. This unusual therapy has been used in previous clinical trials on patients with inflammatory bowel diseases, but the mechanism of action is unclear.

8 Aug 2012

Study reports new potential NOX inhibitor therapy for liver fibrosis

A study published in the online journal Hepatology reports a potential new NADPH oxidase (NOX) inhibitor therapy for liver fibrosis, a scarring process associated with chronic liver disease that can lead to loss of liver function.

8 Aug 2012

Researchers help quell parents' worry about why infants seem to get sick so often

Researchers at the University of Michigan Health System are helping to quell parents' worry about why infants seem to get sick so often.

8 Aug 2012

TXNIP protein provides best available target for therapies against diabetes, Wolfram syndrome

Inflammation and cell stress play important roles in the death of insulin-secreting cells and are major factors in diabetes. Cell stress also plays a role in Wolfram syndrome, a rare, genetic disorder that afflicts children with many symptoms, including juvenile-onset diabetes.

8 Aug 2012

UMass Medical, Serum Institute of India partner on anti-rabies monoclonal antibody pivotal trial

A pivotal clinical trial for an anti-rabies human monoclonal antibody (RMAb) being developed through a collaborative partnership between MassBiologics of the University of Massachusetts Medical School and the Serum Institute of India, Ltd., is starting to enroll patients.

8 Aug 2012

BioDiem granted European patent for antimicrobial drug

Australian vaccine development company BioDiem Ltd (ASX: BDM) announced today the successful granting of a key European patent for its synthetic antimicrobial compound BDM-I. BDM-I is a novel compound active against a range of pathogenic micro-organisms including bacteria, fungi and protozoa. The patent provides protection around BDM-I as a treatment for vulvovaginitis, a general term for inflammation of the vulva or vagina.

7 Aug 2012

Gut microbiota drive metabolic changes in pregnancy

Changes in gut microbiota during pregnancy result in unfavorable metabolic changes that are actually beneficial to a pregnant woman and her developing baby, shows research published in Cell.

7 Aug 2012

Immune System News and Research

Scientists discover new class of polymers that are resistant to bacterial attachment

New 3-D view of the body's response to infection

Promising stem cell therapy may prevent osteoarthritis after joint injury

Allergies appear to lower brain tumor risk

Link between chronic exposure to staph bacteria and risk of lupus

Abacus, SurePoint Medical partner to offer diabetes-care plan for employers

Data from IMUC’s ICT-107 Phase I trial on glioblastoma multiforme accepted for publication

New method gives precise picture of how immune system works

Theranostic imaging targets and tracks potent drug therapies to prostate cancer cells

Covalon’s IV Clear antimicrobial clear silicone dressing to be presented at FIME 2012

Neutrophils help kick off insulin resistance in obesity

Prostate cancer cells can be killed by theranostic imaging without harming healthy cells

Neutral-pressure IV connector eliminates catheter-related bloodstream infections in cancer patients

New clinical trial to study how worm eggs may relieve symptoms of ulcerative colitis

Study reports new potential NOX inhibitor therapy for liver fibrosis

Researchers help quell parents' worry about why infants seem to get sick so often

TXNIP protein provides best available target for therapies against diabetes, Wolfram syndrome

UMass Medical, Serum Institute of India partner on anti-rabies monoclonal antibody pivotal trial

BioDiem granted European patent for antimicrobial drug

Gut microbiota drive metabolic changes in pregnancy

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News